A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Condition(s):Myelofibrosis; Moderate ThrombocytopeniaLast Updated:February 1, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Myelofibrosis; Moderate ThrombocytopeniaLast Updated:February 1, 2024Not yet recruiting
Condition(s):Primary Myelofibrosis; Post-Polycythemia Vera Myelofibrosis; Post-Essential Thrombocythemia Myelofibrosis; Polycythemia Vera; Essential ThrombocythemiaLast Updated:June 18, 2023Completed
Condition(s):Primary Myelofibrosis; Post-Polycythemia Vera; Post-Essential Thrombocythemia MyelofibrosisLast Updated:February 4, 2019Completed
Condition(s):Polycythemia Vera; Essential ThrombocythemiaLast Updated:April 20, 2020Terminated
Condition(s):Primary Myelofibrosis (PMF); Post-polycythemia Vera (Post-PV) Myelofibrosis; Postessential Thrombocythemia (Post-ET) MyelofibrosisLast Updated:June 18, 2023Completed
Condition(s):Neoplasms; Post-polycythemia Vera Myelofibrosis (Post-PV MF); Primary Myelofibrosis (PMF); Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)Last Updated:June 22, 2023Active, not recruiting
Condition(s):Primary Myelofibrosis (PMF); Post-polycythemia Vera (Post-PV); Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)Last Updated:May 23, 2023Completed
Condition(s):Primary Myelofibrosis; Post-Polycythemia Vera Myelofibrosis; Post-Essential Thrombocythemia MyelofibrosisLast Updated:February 1, 2019Completed
Condition(s):Myelofibrosis; Primary MyelofibrosisLast Updated:November 8, 2023No longer available
Condition(s):Primary Myelofibrosis; Post-Polycythemia Vera Myelofibrosis; Post-Essential Thrombocythemia MyelofibrosisLast Updated:May 12, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.